Single dose Sputnik Light shows 93.5% efficacy against Covid, claims RDIF

Sputnik Light tested on 320,000 subjects; no jab-related deaths; no cerebral vein thrombosis and no Guillain-Barre syndrome

Sputnik Light, the single dose version of the Russian Covid-19 vaccine Sputnik V, has shown 93.5 per cent efficacy, claimed the Russian Direct Investment Fund (RDIF) on Wednesday. The data is from Paraguay’s Ministry of Health.

Sputnik Light was tested on 320,000 subjects who received the vaccine based on data collected by July 30, 2021.

The data also indicates a high safety profile of Sputnik Light with no serious adverse events associated with vaccination; no deaths related to the vaccination; no cerebral vein thrombosis (CVT) cases after vaccination; no Guillain-Barre syndrome (GBS) cases after vaccination; no capillary leak syndrome cases